-
Sanja Pajovic
From the Division of Applied Molecular Oncology, Ontario Cancer Institute/Princess Margaret Hospital, Toronto, Ontario, Canada;
-
Timothy W. Corson
Eugene and Marilyn Glick Eye Institute, Department of Ophthalmology, and
Department of Biochemistry and Molecular Biology, Indiana University School of Medicine, Indianapolis, Indiana;
-
Clarellen Spencer
From the Division of Applied Molecular Oncology, Ontario Cancer Institute/Princess Margaret Hospital, Toronto, Ontario, Canada;
-
Helen Dimaras
From the Division of Applied Molecular Oncology, Ontario Cancer Institute/Princess Margaret Hospital, Toronto, Ontario, Canada;
Departments of Molecular and Medical Genetics and
the Vision Science Research Program, Toronto Western Research Institute, Toronto, Ontario, Canada.
-
Marija Orlic-Milacic
From the Division of Applied Molecular Oncology, Ontario Cancer Institute/Princess Margaret Hospital, Toronto, Ontario, Canada;
Departments of Molecular and Medical Genetics and
the Vision Science Research Program, Toronto Western Research Institute, Toronto, Ontario, Canada.
-
Mellone N. Marchong
From the Division of Applied Molecular Oncology, Ontario Cancer Institute/Princess Margaret Hospital, Toronto, Ontario, Canada;
Medical Biophysics, University of Toronto, Toronto, Ontario, Canada; and
the Vision Science Research Program, Toronto Western Research Institute, Toronto, Ontario, Canada.
-
Kwong-Him To
From the Division of Applied Molecular Oncology, Ontario Cancer Institute/Princess Margaret Hospital, Toronto, Ontario, Canada;
Departments of Molecular and Medical Genetics and
the Vision Science Research Program, Toronto Western Research Institute, Toronto, Ontario, Canada.
-
Brigitte Thériault
From the Division of Applied Molecular Oncology, Ontario Cancer Institute/Princess Margaret Hospital, Toronto, Ontario, Canada;
-
Mark Auspitz
From the Division of Applied Molecular Oncology, Ontario Cancer Institute/Princess Margaret Hospital, Toronto, Ontario, Canada;
-
Brenda L. Gallie
From the Division of Applied Molecular Oncology, Ontario Cancer Institute/Princess Margaret Hospital, Toronto, Ontario, Canada;
Departments of Molecular and Medical Genetics and
Medical Biophysics, University of Toronto, Toronto, Ontario, Canada; and
the Vision Science Research Program, Toronto Western Research Institute, Toronto, Ontario, Canada.